Please complete the CAPTCHA to continue
@clintonhealthaccess.org
✓
4 phones found area 919
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Paul L. Domanico (He/Him) is listed as Global Health Research Fellow at the Clinton Health Access Initiative at The Clinton Health Access Initiative, a company with 1600 employees, based in Raleigh-Durham-Chapel Hill Area, United States, United States. AeroLeads shows a work email signal at clintonhealthaccess.org, phone signal with area code 919, and a matched LinkedIn profile for Paul L. Domanico (He/Him).
Paul L. Domanico (He/Him) previously worked as Global Health Research Fellow at The Clinton Health Access Initiative and Senior Director of Global Health Sciences at the Clinton Health Access Initiative at The Clinton Health Access Initiative. Paul L. Domanico (He/Him) holds Phd, Chemistry from Penn State University.
This section adds company-level context without repeating Paul L. Domanico (He/Him)'s masked contact details.
AeroLeads found 1 current-domain work email signal for Paul L. Domanico (He/Him). Compare company email patterns before reaching out.
Dr. Paul L. Domanico is a life science executive and entrepreneur with thirty-eight years of professional experience. He is a multi-faceted, insightful leader with an outstanding record of delivering well-received corporate strategies, new business concepts, and innovative technologies and building productive interdisciplinary teams.Paul has led international and multidisciplinary teams through all phases of drug discovery, development, manufacturing, product access, treatment delivery, and technology development. He has extensive knowledge of drug and diagnostics development, chemistry, biology, information technology, global health, and venture and social capital engagement.As the VP of Technology Development at GSK (2000-2007), Paul and his team have commercialized a suite of technologies that opened new avenues for drug discovery and dramatically improved clinical success.As Founder and Managing Partner at Innovalyst, LLC (2007-2012), Paul and his partners developed a robust methodology that helped clients optimize over a dozen product portfolios, commercialize twenty-six life science technologies, and establish new markets for four existing product lines.As Senior Director of Global Health Sciences at the Clinton Health Access Initiative (CHAI) (2012-2024), Paul delivered an R&D portfolio of new medicines, diagnostics, and technologies, provides clinical science and implementation research leadership, and ensures that healthcare is dramatically improved and sustained for people living in low-resource settings.As Global Health Research Fellow (2024-), Paul leads CHAI work to catalyze the development and delivery of novel science and technology opportunities that promise to transform global health.Paul has built and sustained new organizations in the US, Europe, India, and Africa throughout his career. He creates productive and innovative cultures based on individual and team excellence. He is a business and science mentor and advisor to several global health consortia, science non-profits, universities, and medical schools.
Listed skills include Drug Discovery, Lifesciences, Biotechnology, Biochemistry, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Durham, North Carolina, United States
Dr. Domanico’s role ensures CHAI catalyzes the development and delivery of novel science and technology opportunities that will transform global health. Paul’s objectives are to:- Broaden academic, industrial, government, NGOs, civil society, donor, and other partnerships and collaborations.- Leverage global and corporate relationships to identify, design.
Research Triangle Park, NC, USA
CHAI is a non-profit organization focused on transforming health care in resource-limited regions. The Global Health Sciences department works in partnership with colleagues within CHAI and with industry, academia, and other global health organizations to advance our understanding of disease and service delivery, and support CHAI’s mission to transform.
Dr. Domanico founded Innovalyst, a life sciences consulting company to catalyze product development and commercialization in diagnostics, drug discovery and development, medical devices, and life science informatics. The company includes four managing partners, six principals, and sixty affiliates. Dr. Domanico created and led Innovalyst’s business.
GSK is a world leading pharmaceutical and healthcare companies. With HQ in the UK, they have established major research centers in the UK, USA, Belgium and China.Dr. Domanico created the Department of Technology Development to reduce clinical attrition in drug discovery. He identified, developed and delivered advanced technologies for drug discovery and.
Research Triangle Park, NC
Dr. Domanico led an international department of forty that developed and implemented a suite of novel technologies for drug discovery. He integrated the disciplines of biochemistry, chemistry, computer science, engineering, and logistics, and managed a development portfolio that involved over 100 scientists.Under Dr. Domanico’s leadership, this group.
RTP, NC
Dr. Domanico developed the high throughput screening strategy for GlaxoWellcome Research, US. He created strategic alliances with companies and institutes worldwide. Under Dr. Domanico’s leadership, his department developed the following platforms in support of high throughput screening:- Screening - Flexible, ultra-high throughput screening platform and.
Wilmington, DE
Dr. Domanico studied the chemical and conformational steps involved in the relaxation of supercoiled double-stranded DNA by E. coli topoisomerase I and the in vivo regulation of this protein. He synthesized oligodeoxynucleotides analogs and used them to probe the enzyme's active site for substrate specificity. He analyzed the response of the kinetic.
Other employees you can reach at clintonhealthaccess.org. View company contacts for 1600 employees →
Tamana Richard
Colleague at The Clinton Health Access InitiativePort Harcourt, Rivers State, Nigeria, Nigeria
View →
KA
Khursheed Aalam
Colleague at The Clinton Health Access InitiativeSrinagar, Jammu & Kashmir, India, India
View →
TS
Timothy Silweya
Colleague at The Clinton Health Access InitiativeLusaka, Lusaka Province, Zambia, Zambia
View →
AN
Aisha Ndanusa
Colleague at The Clinton Health Access InitiativeNigeria, Nigeria
View →
RK
Rajiv Kaushik
Colleague at The Clinton Health Access InitiativeBhopal, Madhya Pradesh, India, India
View →
OA
Oshin Ajmal
Colleague at The Clinton Health Access InitiativeTamil Nadu, India, India
View →
MT
Mimi Ta
Colleague at The Clinton Health Access InitiativeKenya, Kenya
View →
RN
Raymond Ngeno
Colleague at The Clinton Health Access InitiativeKenya, Kenya
View →
TM
Talkmore Maruta
Colleague at The Clinton Health Access InitiativeLesotho, Lesotho
View →
BD
Bongani Dube
Colleague at The Clinton Health Access InitiativeHarare, Zimbabwe, Zimbabwe
View →
Dr. Domanico studied the mechanism of the enzymatic hydrolysis of phosphorothioate enzyme substrate analogs and the non-enzymatic.
Quick answers generated from the profile data available on this page.
Paul L. Domanico (He/Him) works for The Clinton Health Access Initiative.
Paul L. Domanico (He/Him) is listed as Global Health Research Fellow at the Clinton Health Access Initiative at The Clinton Health Access Initiative.
AeroLeads has found 1 work email signal at @clintonhealthaccess.org for Paul L. Domanico (He/Him) at The Clinton Health Access Initiative.
AeroLeads has found 4 phone signal(s) with area code 919 for Paul L. Domanico (He/Him) at The Clinton Health Access Initiative.
Paul L. Domanico (He/Him) is based in Raleigh-Durham-Chapel Hill Area, United States, United States while working with The Clinton Health Access Initiative.
Paul L. Domanico (He/Him) has worked for The Clinton Health Access Initiative, Innovalyst, Llc, Glaxosmithkline, Glaxowellcome, and Glaxowellcome Research Institute.
Paul L. Domanico (He/Him)'s colleagues at The Clinton Health Access Initiative include Tamana Richard, Khursheed Aalam, Timothy Silweya, Aisha Ndanusa, and Rajiv Kaushik.
You can use AeroLeads to view verified contact signals for Paul L. Domanico (He/Him) at The Clinton Health Access Initiative, including work email, phone, and LinkedIn data when available.
Paul L. Domanico (He/Him) holds Phd, Chemistry from Penn State University.
Paul L. Domanico (He/Him) is listed with skills including Drug Discovery, Lifesciences, Biotechnology, Biochemistry, Strategy, Technology Transfer, Pharmaceutical Industry, and Commercialization.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts